Clinical-stage USA-based drug developer Inhibikase Therapeutics saw its shares tumble more than 31% to $1.92, after is ...

After hours: 31 January at 17:10:45 GMT-5 ...

President Trump plans to impose tariffs on more than 40% of all U.S. imports, the most in nearly a century.

The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap ...

UK pharma major AstraZeneca has scrapped its plans to invest £450 million in expanding ($559 million) to expand its vaccine plant in Speke, Liverpool, blaming a reduction in government support. This ...

DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, ...

On December 17, 2024, Ultimovacs announced an agreement to combine its business with Zelluna Immunotherapy AS and the intention to launch a fully committed private placement. Zelluna Immunotherapy is ...

After hours: February 3 at 6:52:05 PM EST Loading Chart for SCPH ...

After hours: February 3 at 5:43:47 PM EST Loading Chart for KURA ...

After hours: February 3 at 5:59:16 p.m. EST ...

After hours: 7:18:35 p.m. EST ...